WHO ICTRP trial
Effects of sugammadex on early postoperative recovery and pulmonary…
ChiCTR2100054381 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100054381 |
|---|---|
| Public title | Effects of sugammadex on early postoperative recovery and pulmonary complications in patients undergoing thoracoscopic-laparoscopic radical esophagectomy |
| Scientific title | Effects of sugammadex on early postoperative recovery and pulmonary complications in patients undergoing thoracoscopic-laparoscopic radical esophagectomy |
| Primary sponsor | Affiliated Cancer Hospital of Zhengzhou University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Esophageal cancer |
| Interventions | Control group1:Intravenous neostigmine 0.04 mg/kg in combination with atropine 0.5 mg, while stopping intravenous pumping of anaesthetic drugs;Control group2:Intravenous neostigmine 0.04 mg/kg in combination with atropine 0.5 mg, with… |
| Registration date | Dec 16, 2021 |
| Target size | Control group1:30;Control group2:30;Experimental group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: